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Abstract
Objective—Sleep homeostasis is altered in major depressive disorder (MDD). Pre-to post-sleep
decline in waking auditory evoked potential (AEP) amplitude has been correlated with sleep slow
wave activity (SWA), suggesting that overnight changes in waking AEP amplitude are
homeostatically regulated in healthy individuals. This study investigated whether the overnight
change in waking AEP amplitude and its relation to SWA is altered in MDD.
Method—Using 256-channel high-density electroencephalography, all-night sleep
polysomnography and single-tone waking AEPs pre-and post-sleep were collected in 15 healthy
controls (HC) and 15 non-medicated individuals with MDD.
Results—N1 and P2 amplitudes of the waking AEP declined after sleep in the HC group, but not
in MDD. The reduction in N1 amplitude also correlated with fronto-central SWA in the HC group,
but a comparable relationship was not found in MDD, despite equivalent SWA between groups.
No pre-to post-sleep differences were found for N1 or P2 latencies in either group. These findings
were not confounded by varying levels of alertness or differences in sleep variables between
groups.
Conclusion—MDD involves altered sleep homeostasis as measured by the overnight change in
waking AEP amplitude. Future research is required to determine the clinical implications of these
findings.
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Introduction
Sleep disturbances in major depressive disorder (MDD) have both diagnostic and functional
significance (1–3). Alterations in sleep continuity (4), rapid eye movement (REM) sleep (1,
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5), and non-REM (NREM) sleep have been demonstrated in MDD. In NREM sleep, slow
wave activity (SWA; sleep EEG power in the 1–4.5Hz range) has been established as a
marker of sleep homeostasis, as it increases in proportion to prior wakefulness and declines
with sleep (6–9). Regulation of these homeostatic processes, as measured by SWA, has been
shown to be aberrant in MDD (10–12).
In addition to sleep SWA, waking auditory evoked potentials (AEPs), a readily collected
measure of auditory processing, have also been linked to homeostatic function. A recent
investigation demonstrated that the amplitudes of AEP N1 and P2 components significantly
decline pre-to post-sleep, most prominently over a fronto-central region of the cortex (13).
Additionally, the overnight change in N1 amplitude correlated with SWA from that night,
suggesting sleep-related homeostatic regulation of these AEP components.
Given the demonstrated abnormalities in MDD related to sleep homeostasis, combined with
the evidence that overnight change in waking AEP amplitude is a sleep-related homeostatic
process, pre-to post-sleep changes in waking AEP amplitude could provide valuable
information regarding the altered regulation of sleep homeostasis observed in MDD.
Therefore, the current study employed a common auditory oddball technique and spectral
analysis of sleep using high-density EEG (hdEEG) in healthy controls and individuals with
MDD.
Aims of the study
This study investigated the overnight change in auditory evoked potential amplitude in
healthy controls and participants with major depressive disorder (MDD). We hypothesized
that the control group would demonstrate a pre-to post sleep decline in N1 and P2 amplitude
that would correlate with sleep slow wave activity, while the MDD group would fail to show
a comparable sleep-related decline in N1 or P2 amplitude.
Material and methods
Participants
30 right-handed individuals, including 15 MDD participants and 15 healthy controls (HC),
were recruited from a larger study on sleep homeostasis in depression. MDD was diagnosed
via the Structured Clinical Interview for DSM-IV Axis I disorders (SCID) (14), and global
depression severity was evaluated with the clinician-administered 17-item Hamilton Rating
Scale for Depression (15). MDD participants were unipolar, non-psychotic, and medication-
free for ≥ 6 months prior to the study. HC participants were evaluated with the non-patient
version of the SCID to rule out current or past psychiatric disorders (16).
All participants provided informed consent and were instructed to maintain regular sleep-
wake schedules, avoid napping, and to limit the use of caffeinated or alcoholic beverages to
no more than 1 drink per day and none after 2 p.m. for the duration of the study. Adherence
was verified via sleep diaries and wrist motor actigraphy (Actiwatch, Mini-Mitter, Bend,
OR). This study was approved by the Institutional Review Board of the University of
Wisconsin-Madison.
Study design
All participants underwent in-laboratory polysomnography (PSG) prior to their experimental
night, which served to both acclimate participants to the laboratory environment and to rule
out clinically significant sleep-disordered breathing (apnea-hypopnea index > 10/hr) or
sleep-related movement disorders (periodic limb movement-arousal index > 10/hr). PSG
included standard monitoring with electrooculogram (EOG), sub-mental electromyogram
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(EMG), electrocardiogram (ECG), bilateral tibial EMG, respiratory inductance
plethysmography, pulse oximetry, and a position sensor. To reduce potential confounds
caused by low total sleep time and sleep fragmentation, individuals with sleep efficiency
(total sleep time/time in bed) < 80% were excluded from the study.
On the experimental night, participants arrived at the laboratory between 20:00 and 21:00
and were outfitted with 256-channel hdEEG (Electrical Geodesics Inc., Eugene, OR).
Participants sequentially performed a Psychomotor Vigilance Task (PVT) (17), an auditory
oddball task, and a visuo-motor learning task (18), then slept undisturbed in the laboratory
starting within one hour of their reported usual bedtime. The following morning, participants
were woken up after at least 7 hours of sleep and performed the tasks from the previous
evening in the same sequential order. The morning tasks were performed at least 30 minutes
after awakening to minimize effects of sustained drowsiness after waking (19). All AEP and
sleep hdEEG recordings were collected with vertex-referencing, using NetStation software
(Electrical Geodesics Inc., Eugene, OR) and DC amplifiers with200Hz analog low-pass
filters. To increase the signal-to-noise ratio, all hdEEG processing and analyses were
restricted to the 185 channels overlaying the scalp (20).
Auditory oddball task
AEPs for each participant were gathered using a standard oddball paradigm (13, 21, 22),
delivering sinusoidal tones of 50 msec duration and frequencies of 800 Hz (standard) or 560
Hz (target) using E-Prime (Psychology Software Tools Inc., Pittsburgh, PA). A total of 96
standard and 24 target stimuli were presented at each time point with an inter-stimulus
interval that varied randomly between 1900 and 3190 msec. Tones were presented
binaurally at an unchanging, comfortable volume through circumaural headphones or
earbuds. Throughout each recording, participants were instructed to sit comfortably with
eyes open, fixating at a point 90 cm in front of them, while counting the number of low-
frequency (target) tones.
To ensure a high signal-to-noise ratio when averaging the evoked responses, data processing
and analysis for each time point were restricted to the 96 standard tones. The AEP
recordings were sampled at 500Hz, first-order high-pass filtered (Kaiser type FIR, 0.1 Hz),
bandpass filtered (Kaiser type FIR, 1–15 Hz), and segmented (100 msec pre-to 500 msec
post-stimulus). Data cleaning was performed automatically, whereby channels in each
segment were marked as artifact if the maximum amplitude difference of the entire segment
was greater than 100 μV or less than .05 μV, or if the maximum amplitude difference within
a moving window of 80 msec was greater than 150 μV (for ocular artifacts). Segments were
removed if they contained more than 20 artifactual channels or any ocular artifacts.
Artifactual channels in the remaining segments were replaced using spherical spline
interpolation. Visual inspection of the data was then performed using topographical maps
and synoptic plots, but no further channels or segments were removed. The mean percentage
of trials retained for AEP averaging was at least 80% of total segments for each group (HC:
82.11 ± 14.65%; MDD: 85.38 ± 16.80%), consistent with prior studies (23, 24). Finally, data
from the 185 channels were re-referenced using linked mastoids and baseline corrected by
subtracting the average voltage during the 100 msec preceding the tone.
The peak N1 and P2 amplitudes for each channel were identified as the most negative value
between 40 and 140 msec and the most positive value between 142–262 msec post-stimulus,
respectively (13). Latencies to N1 and P2 peaks were additionally identified for analysis.
The average of a fronto-central cluster of channels was calculated for pre-and post-sleep
recordings for overnight comparisons by time. To measure global brain activation of the
AEPs (13, 25, 26), global mean field power (GMFP) was calculated as the root mean square
of the instantaneous voltage distribution across all 185 channels.
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Sleep recordings
All-night hdEEG recordings were sampled at 500 Hz, first-order high-pass filtered (Kaiser
type, 0.6 Hz), downsampled to128 Hz, band-pass filtered (2-way least-squares FIR, 1–40
Hz), and average-referenced. Semi-automatic artifact rejection was conducted to remove
channels with high-frequency noise or interrupted contact with the scalp for the majority of
the recording. Spectral analysis was performed for each channel in consecutive 6-second
epochs (Welch’s averaged modified periodgram with a Hamming window). Sleep staging
was based on 6 bipolar mastoid-referenced channels (F3, F4, C3, C4, O1, and O2), sub-
mental EMG and EOG, and was performed by a registered polysomnographic technologist
in 30-second epochs according to standard critera using Alice® Sleepware (Philips
Respironics, Murrysville, PA) (27).
Statistics
Overnight differences (pre-vs. post-sleep) in N1 and P2 amplitude and latency of the AEP
within each group were examined using 2-tailed, paired t-tests. To correct for multiple
comparisons of the topographical hdEEG data, statistical non-parametric mapping with
suprathreshold cluster tests (STCT) was employed (13, 28). For a cluster of channels to be
significant, it had to be larger than 95% of the clusters in the maximal cluster size
distribution. To compare pre-sleep AEP latency and amplitude, as well as polysomnographic
variables between groups, 2-tailed unpaired (homoscedastic) t-tests were used. For
correlational analyses, AEP and hdEEG sleep data were first cleaned for outliers using a
threshold of ± 2.5 standard deviations from the mean at each channel. Statistical dependence
between variables at each channel and frequency bin was assessed using linear regression.
Descriptive statistics are expressed as mean ± standard deviation. Statistical analyses were
performed using MATLAB (The MathWorks Inc., Natick, MA) and STATISTICA (StatSoft
Inc., Tulsa, OK).
Results
Demographic, clinical, and polysomnographic data
Table 1 displays descriptive statistics and P values for between group comparisons. MDD
and HC groups did not differ in age. Both groups consisted of male and female participants,
with a slightly higher proportion of women in the MDD group (10/15 vs. 8/15). HRSD-17
scores for MDD participants ranged from 8 to 25, indicating mild to moderate depression
severity (15). Mean number of lifetime major depressive episodes was 10.1 ± 11.9 (range:
1–30), and mean duration of the current episode was 7.2 ± 3.2 weeks. 6 MDD participants
met criteria for melancholic and 3 for atypical depression subtype. In addition to their
principal diagnosis of MDD, 6 participants had comorbid anxiety disorders (5 generalized
anxiety disorder, 1 post-traumatic stress disorder). No participants had current or a past
history of drug or alcohol dependence. On the initial screening PSG, MDD and HC groups
did not demonstrate significantly different indices of sleep-disordered breathing (AHI) or
sleep fragmentation due to nocturnal myoclonus (PLM-AI).
There was no difference between HC and MDD groups for lights-off (23:04 ± 41 min. vs.
23:06 ± 18 min., P = 0.841)or lights-on (06:46 min. ± 39 vs. 06:47 ± 49 min., P = 0.956).
Additionally, no significant differences between groups were observed for total sleep time
(TST), wake after sleep onset, sleep efficiency, sleep onset latency, amount of NREM sleep
(% of TST), or REM latency. However, the MDD group exhibited a higher arousal index (T
= 2.24, P = 0.033) and trended toward a greater percentage of REM sleep (T = 1.75, P =
0.092). There was no significant difference in the amount of all-night global SWA between
MDD and HC groups. Additional exploratory analyses demonstrated no significant
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differences in global SWA between groups for any NREM episode, nor significant
differences in topographic SWA for all-night or NREM episodes1–4.
Overnight change in N1 and P2 amplitude
The auditory oddball task was administered at similar times for HC and MDD groups (Pre-
sleep: 21:31 ± 25 min. vs. 21:29 ± 15 min., P = 0.793; Post-sleep: 07:25 ± 43 min. vs. 07:30
± 42 min., P = 0.722). Consistent with previous research (13), the HC group demonstrated a
significant decline in AEP amplitude pre-to post-sleep within the N1 (84–140 msec) and P2
(188–206 msec) ranges (Fig. 1a). GMFP, a measure of global brain activation following the
auditory stimulus, also showed a significant overnight reduction in N1 (92–134 msec)
amplitude for HC participants (Fig. 1b). However, the MDD group did not show a
comparable overnight reduction in N1 or P2 amplitude (Figs. 1c and 1d). When comparing
mean AEP amplitude between groups, no significant pre-sleep difference was observed for
N1 or P2 amplitude, but the MDD group had greater post-sleep N1 amplitude compared to
controls (−7.37 ± 4.96 vs. −4.26 ± 2.95, P = 0.046, averaged across 108–128 msec post-
stimulus). For latencies of the AEP peaks, no overnight differences were observed for N1 or
P2 components in either group.
Topographic representations of AEP amplitude pre-and post-sleep, as well as the overnight
change, are displayed in Fig. 2. For the N1 component, both HC and MDD groups showed
the typical scalp distribution of fronto-central negativity with peripheral polarity reversal
(13, 29, 30) (Fig. 2a), but a significant overnight reduction in amplitude within a fronto-
central group of channels (using STCT) was observed only in the HC group (Fig. 2b). For
the P2 component, the typical scalp distribution of the signal was again observed in both
groups (Fig. 2c), while an overnight reduction in amplitude was observed for the HC group,
but not for the MDD group (Fig. 2d).
With the same topographic analysis stratified by sex, females and males within each group
showed similar patterns of overnight change in AEP amplitude and latency. The overnight
change in AEP amplitude was also similar for MDD participants with and without comorbid
anxiety. In addition, there were no significant differences in pre-vs. post-sleep vigilance
level as measured by the PVT for either group, and AEP latency did not correlate with PVT
values pre-or post-sleep.
Topographic correlations
Given the overnight change in AEP amplitude specific to a fronto-central region, as well as
previous research demonstrating a relationship between the overnight change in N1
amplitude and low-frequency SWA (1–2.33Hz) in healthy controls (13), topographic
correlations were performed for both groups. Consistent with Hulse et al. (13), a fronto-
central cluster of channels showed a significant correlation between the decline in N1
amplitude and average all-night low-frequency SWA in the HC group (Fig. 3a). When
examined across a range of spectral activity during sleep using a representative fronto-
central channel, the overnight decline in N1 amplitude in healthy controls correlated most
significantly with frequencies <4Hz, along with a correlation in the alpha range around 9 Hz
(Fig. 3b). In contrast, change in N1 amplitude in the MDD group did not correlate
topographically with low-frequency SWA (Fig 3c), or any other frequency <20Hz (Fig. 3d).
No significant correlations were found between either the overnight change in P2 amplitude
or GMFP measures of global brain activation, and SWA for either group. In addition, no
significant correlations were observed for either group between the overnight change in N1
or P2 amplitude and standard polysomnographic variables (listed in Table 1). Within the
MDD group, neither the pre-or post-sleep AEP amplitude, nor the overnight change in
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amplitude, significantly correlated with global depression severity as measured by the
HRSD-17.
Discussion
Using a standard waking auditory oddball task pre-and post-sleep, this study replicated
previous findings by Hulse et al. (13) with a separate group of healthy individuals, showing
that auditory evoked potential (AEP) N1 and P2 amplitudes decline after a night of sleep and
that the overnight change in N1 amplitude is proportional to the amount of slow wave
activity (SWA) from that night. When applying the same technique to a group of
participants with major depressive disorder (MDD), however, neither a comparable
overnight decline in N1 or P2 amplitude, nor a relationship between overnight AEP
amplitude change and SWA was observed.
According to PSG variables from the experimental night, MDD and HC groups showed
comparable sleep profiles. The elevated arousal index and REM sleep amount in MDD
compared to HC are consistent with previous studies (1, 5, 31). Despite these differences,
none of the PSG variables correlated with the overnight change in AEP amplitude,
suggesting that overall sleep architecture was not differentially impacting the AEP results
across groups.
Varying states of vigilance or attention, such as sleep inertia experienced in the morning
after awakening (32), could have impacted AEP amplitude or latency, but all participants
were given sufficient time in the morning before beginning the tasks (19), supported by
equivalent PVT and AEP latency values pre-vs. post-sleep and between groups (21, 33, 34).
Moreover, PVT values did not correlate with pre-or post-sleep AEP amplitude values.
Studies have also demonstrated an impact of antidepressant medication on auditory
processing in animals and humans (35–37). Because MDD participants were free of
pharmacological treatment for at least 6 months prior to the study, it is unlikely that
antidepressant medication biased the results observed in this study. In addition, although the
MDD group included two more females than the HC group, no differences were observed in
terms of overnight change in AEP amplitude when conducting stratified analyses. However,
because prior literature has suggested SWA in MDD may be different in women versus men
(11, 38), sex-related effects on homeostatic processes, including overnight change in AEP,
may be an important area of future investigation.
Previous literature regarding baseline comparisons of AEP N1 and P2 components between
MDD and healthy controls has yielded conflicting results. Increased N1 latency and
amplitude (39, 40), and decreased P2 amplitude have been demonstrated (39), whereas other
studies have shown no difference in N1 amplitude and increased P2 amplitude (41, 42). It is
possible that unmeasured factors such as time of day of the recordings, which may affect
both circadian and/or homeostatic processes (43, 44), influenced the observed AEP
amplitude and latency in previous studies. For example, Kerkhof and colleagues (45)
previously demonstrated that morning-type individuals had greater N1-P2 amplitude overall
compared to evening-types, suggesting that intrinsic circadian preference may affect AEP
amplitude. Although AEP recordings and sleep times were similar between MDD and HC
groups in this investigation, circadian phase was not rigorously measured in our study
design, and thus differential circadian modulation of AEP amplitude between groups could
potentially explain the observed difference in pre-to post-sleep amplitude changes.
However, bed times and waking times, as well as time of administering the oddball task did
not significantly differ between groups. To clarify the degree to which circadian and
homeostatic factors contribute to overnight changes in AEP amplitude, the use of constant
routine and/or forced desynchrony protocols may be beneficial in future research.
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This study replicates previous work (13) demonstrating the overnight decline in N1
amplitude correlates with SWA in healthy controls, which suggests that this AEP measure
reflects a sleep homeostatic process. However, it is noteworthy that in this study, MDD and
HC had similar SWA values, both all-night and across NREM episodes, despite lack of
overnight decline in N1 amplitude in the MDD group. Because SWA has been widely used
as a measure of sleep homeostasis (6–9), one might expect alterations in sleep homeostasis
to be reflected by different SWA values between HC and MDD groups. However, our
results of similar SWA values between HC and MDD groups are not dissimilar with other
reports that have failed to demonstrate significant differences in baseline SWA in MDD
relative to healthy subjects (12, 46, 47). In addition, SWA in MDD is moderated by effects
of age and sex (11, 12, 48), and thus the lack of difference in SWA between HC and MDD
groups in this study may have been due to the narrow age range of participants, different sex
distributions, and/or inadequate power to detect such differences between groups. An
alternative hypothesis for our findings would be that SWA may be present, but
dysfunctional in MDD, which could explain the lack of relationship between overnight
change in N1 amplitude and SWA for the MDD group. In this case, overnight change in
AEP amplitude could be a more sensitive measure for or reflect a different aspect of sleep
homeostasis in MDD that is not fully captured by SWA. To more critically examine the
homeostatic nature of AEP amplitude and its relationship to SWA, future studies would
benefit from delivering a challenge to normal sleep, such as sleep delay or restriction
protocols (12), in both MDD and control samples.
Several studies have linked both AEP N1 and P2 components with central auditory plasticity
(49–53). In the present study, a greater decline in N1, but not P2, amplitude was associated
with greater SWA from that night in healthy controls. In accordance with previous literature
(13, 34, 50, 53), it is likely that the N1 and P2 components involve separate processes,
especially when considering their relationship to sleep. Given that sleep SWA has also been
linked to synaptic plasticity (8, 54, 55), and MDD may involve deficiencies in plastic
processes (56–58), it is possible that the present findings, particularly involving the AEP N1
component, reflect alterations in sleep-regulated synaptic plasticity in MDD.
This study was designed to be an initial investigation of the overnight change in AEP
amplitude in a broad sample of unipolar, non-psychotic MDD participants. Given the
heterogeneous nature of MDD (59, 60), we investigated the pattern of overnight AEP
change in the subgroup of MDD individuals with comorbid anxiety. However, when
comparing this subgroup with the entire MDD sample, similar patterns were observed,
suggesting that the alterations in the overnight change in AEP were likely related to the
primary diagnosis of MDD, rather than comorbid disorders. Furthermore, although no
correlations between HRSD-17 scores and AEP values were found in this study, it is
possible that global severity or specific symptomatology, such as suicidality, may play a role
in sleep-related regulation of auditory processing in MDD (42, 61). Thus, examination of
overnight changes in AEP amplitude in more severe MDD participants without comorbidity
may further clarify the relationship between homeostatic regulation of AEP components and
MDD.
Along with sleep and spontaneous waking EEG measures of homeostatic processes (3, 62,
63), waking AEP techniques have been shown to predict response to therapeutic sleep
deprivation (64, 65), and, particularly when measuring the loudness-dependence of the AEP
(LDAEP), response to pharmacotherapy (66–68). Given the robust findings of research
using LDAEP measures, in combination with the results of the present study, it would be
intriguing to examine whether overnight changes in the LDAEP could further reveal MDD
subgroups of diagnostic or prognostic value.
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Significant Outcomes
• In healthy controls, N1 and P2 amplitudes of the auditory evoked potential
(AEP) were reduced after a night of sleep, and greater overnight reduction in N1
amplitude was related to greater sleep slow wave activity (SWA).
• for the major depressive disorder (MDD) group, neither a significant overnight
decline in AEP amplitude, nor a comparable relationship with sleep SWA was
observed.
• The results were not confounded by varying levels of alertness or differences in
sleep variables between groups.
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Limitations
• This study involved a broad sample of MDD participants with variable
depression severity and a moderate proportion of comorbid anxiety disorders.
• This study was not designed to distinguish the impact of circadian rhythms on
overnight changes in AEP amplitude.
• Multi-tone AEP paradigms could further elucidate sleep-related abnormalities in
MDD.
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Fig. 1.
Overnight comparison of AEP amplitude by time in healthy control (HC) and depressed
(MDD) groups. (a) Pre-and post-sleep AEP raw amplitude from the average of a fronto-
central cluster of channels and (b) global mean field power (GMFP) in controls. (c,d)
Identical raw amplitude and GMFP plots for the MDD group. Dotted vertical lines signify
stimulus onset. Samples in the N1 and P2 ranges with significant pre-vs. post-sleep
differences (P < .05) pre are denoted by a solid black line.
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Fig. 2.
Topographic distribution of pre-and post-sleep AEP amplitude and overnight change. (a)
Pre-and post-sleep values of the peak amplitude at each channel within the N1 range for HC
and MDD groups. (b) Overnight change in N1 amplitude for each channel, represented as
the absolute difference. Channels with significant overnight differences using STCT are
denoted by white dots. (c,d) Same as in (a,b) for the P2 range.
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Fig. 3.
Relationship between overnight change (%) in N1 amplitude and average all-night sleep
EEG power. (a) Topographic correlations (r – values) of N1 change with SWA (1–2.33Hz)
at each channel for the HC group. White dots signify channels with P < .05. (b) Frequency-
specific correlations from a representative fronto-central channel for HC. Black bars denote
frequency bins with P < .05. (c,d) Same as in (a,b) for the MDD group.
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Table 1
Demographic, clinical, and polysomnographic data
HC (N = 15) MDD (N = 15) P
Sex (male/female) 7/8 5/10
Age (years) 21.40 (1.55) 22.40 (2.67) 0.220
HRSD-17 -- 16.27 (5.02)
AHI* (#/hr.) 0.57 (1.12) 0.54 (0.73) 0.939
PLM-AI* (#/hr.) 2.23 (2.85) 2.36 (2.85) 0.902
TST (min.) 430.30 (28.74) 409.20 (56.38) 0.207
WASO (min.) 25.97 (21.33) 25.73 (21.56) 0.976
AI (#/hr.) 7.56 (4.13) 11.34 (5.07) 0.033
SE (%) 91.48 (5.59) 90.25 (7.01) 0.598
SOL (min.) 15.10 (15.49) 17.73 (12.86) 0.612
N1 (%) 5.90 (3.79) 7.05 (4.02) 0.426
N2 (%) 58.47 (7.06) 54.71 (11.71) 0.296
N3 (%) 16.53 (5.71) 14.81 (10.32) 0.577
SWA 45.08 (38.25) 41.36 (26.51) 0.759
REM (%) 19.13 (6.11) 23.42 (7.28) 0.092
REML (min.) 95.40 (37.64) 89.10 (50.89) 0.703
HC, healthy control; MDD, major depressive disorder; HRSD-17, Hamilton Rating Scale for Depression (17-item); AHI, apnea-hypopnea index;
PLM-AI, periodic limb movement-arousal index; TST, total sleep time; WASO, wake (time) after sleep onset; AI, arousal index; SE, sleep
efficiency; N1/2/3, NREM stage 1/2/3 (% of TST); SWA, slow wave activity (EEG power in 1–2.33 Hz range); REM, stage REM (% of TST);
REML, REM latency Values are displayed as mean (standard deviation). 2-tailed, independent samples t-tests were used.
*Values are from initial screening night. All other polysomnographic variables reflect the experimental night.
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